Dror Harats - Free People Check with News, Pictures & Links

	Israel San francisco

	CEO Chief Executive Chief Executive Officer Executive Officer Medical Center Vascular Biogenics Ltd Yehuda

Images of Dror Harats

(1 - 1 from 1 )

News

(1 - 4 from 9

–show all

)

VBLT Company Profile & Executives - Vascular Biogenics Ltd. - Wall...

www.wsj.com

VBLT - key executives, insider trading, ownership, revenue and average growth rates. Detailed company description & address for Vascular Biogenics Ltd..

Dror Harats Archives - World Israel News

worldisraelnews.com

Tagged Dror Harats. WATCH: Israeli drug doubles survival time for patients with brain tumors. Get the Latest Israel News! Follow @worldisraelnews. United With Israel. Tweets by @worldisraelnews ...

Prof. Dror Harats | The Times of Israel

www.timesofisrael.com

News from Israel, the Middle East and the Jewish World

Vascular Biogenics' (VBLT) CEO Dror Harats on Q Results -...

www.hstong.com

Company Participants. Michael Wood – LifeSci Advisors. Dror Harats – Chief Executive Officer. Amos Ron – Chief Financial Officer. Conference Call Participants.

Telephone & Addresses

Dror Harats, San Francisco, US, Locksley Ave, Apt 5C

View Dror's social profiles and photos on Facebook, MySpace, and +40 Networks.

Dror Harats, San Francisco, US, Locksley Ave, Apt 6K

View Dror's social profiles and photos on Facebook, MySpace, and +40 Networks.

Network Profiles

(1 - 4 from 6

–show all

)

Dror Harats | Semantic Scholar

www.semanticscholar.org

Semantic Scholar profile for undefined, with 4 scientific research papers.

PROF. DROR HARATS, MD - American Friends of Sheba ...www.shebamedical.org › people › prof-dror-harats-md

www.shebamedical.org

Prof. Dror Harats, MD. About Friends of Sheba. About Us · Contact Us · Make a Donation. Subscribe. Stay up to date with information from American Friends of ...

Interests

Dror Harats patents Recent bibliographic sampling of Dror Harats patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title): Interleukin-1 (il-1) inhibitors for treating fertility disorders

Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q Results -...

seekingalpha.com

· Vascular Biogenics Ltd. (NASDAQ:VBLT) Q Earnings Conference Call May 15, :30 AM ET Company Participants Michael Wood - LifeSci Advisors Dror Harats - …

Education

Dror Harats - Biography

www.marketscreener.com

Founder of Vascular Biogenics Ltd., Dror Harats currently holds the position of Chief Executive Officer & Director at Vascular Biogenics Ltd. and Director of...

Books & Literature

(1 - 3 from 5

–show all

)

PLOS ONE: The Inhibition of Macrophage Foam Cell Formation by 9-Cis...

journals.plos.org

Dror Harats. Affiliations The Bert W. Strassburger Lipid Center, Sheba Medical Center, Tel-HashomerRamat-Gan, Israel, Sackler ...

Atherosclerosis and Autoimmunity - Google Books

books.google.ch

Presenting further studies in the prevention and treatment of coronary artery disease, this book brings together the knowledge accrued in the past decade...

The Alga Dunaliella - Google Books

books.google.ch

This volume presents a state-of-the art research in biochemistry, molecular biology and medical application. A glossary of specialized terms is appended. Each...

Scientific Publications

Atherosclerosis and Autoimmunity | ScienceDirect

www.sciencedirect.com

Atherosclerosis and Autoimmunity. Section V—Anti-Endothelial Cell Antibodies and Athrrosclerosis. Book • Edited by: Yehuda Shoenfeld, Dror Harats, .

Publications

Prevention of Atherosclerosis Progression by 9-cis-β ...www.hindawi.com › journals › bmri › citations

www.hindawi.com

... Ayelet Harari, Ami Ben-Amotz, Yehuda Kamari, Dror Harats, and Aviv Shaish, “The Inhibition of Macrophage Foam Cell Formation by 9-Cis ...

Autoimmunity in atherosclerosis | SpringerLink

link.springer.com

Autoimmunity in atherosclerosis. The role of autoantigens. Jacob George ,; Dror Harats &; Yehuda Shoenfeld. Clinical Reviews in Allergy & Immunology volume ...

Reports & Statements

Effect of Telmisartan, Angiotensin II Receptor Antagonist, on ...www.nature.com › ... › original article

www.nature.com

... Edna Peleg ,; Yehonatan Sharabi ,; Dror Harats &; Ehud Grossman. Hypertension Research volume 31, pages135–140(2008)Cite this article.

Miscellaneous

(1 - 17 from 24

–show all

)

Dror Harats - CEO at VBL | The Org

theorg.com

View Dror Harats at VBL on The Org

Dror Harats Net Worth (2022) | wallmine

wallmine.com

Prof. Dror Harats serves as Chief Executive Officer and Director of Vascular Biogenics Ltd since January He has founded the Company in ...

Prof. Dror Harats - IVC Research Centerwww.ivc-online.com › Google-Card

www.ivc-online.com

Prof. Dror Harats. Key Executive. Experience. Contact Info. CV. Please register or purchase search results to see more information card.

VASCULAR BIOGENICS LTD. : Actionnaires Dirigeants et Profil Société |...

www.zonebourse.com

VASCULAR BIOGENICS LTD. : Présentation de la société VASCULAR BIOGENICS LTD., actionnaires, dirigeants, description métier, rating financiers, communiqués...

Genuine Parts Company (GPC) CEO Dror Harats on Definitive ...

www.nasdaq.com

» Genuine Parts' (GPC) CEO Paul Donahue on Q Results - Earnings Call Transcript » Genuine Parts (GPC) Q Results - Earnings Call Transcript Good day, everyone. And welcome to the ...

Prof. Dror Harats MD | IAC | Israeli American Council

www.israeliamerican.org

Prof. Harats also serves as Chairman of the Institutional Review Board (IRB) and President of the Bert Strassburger Lipid Center at Sheba Medical Center.

Vascular Biogenics' (VBLT) CEO Dror Harats on Q

www.nasdaq.com

Join the Nasdaq Community today and get free, instant access to portfolios, stock ratings, real-time alerts, and more!

(PDF) 9-cis β-carotene-rich powder of the alga Dunaliella bardawil...

www.academia.edu

9-cis β-carotene-rich powder of the alga Dunaliella bardawil increases plasma HDL-cholesterol in fibrate-treated patients

9-cis β-Carotene–Enriched Diet Inhibits Atherogenesis and Fatty Liver...

academic.oup.com

Abstract. Our aim was to study the effect of 9-cis β-carotene–rich powder of the alga Dunaliella bardawil on lipid profile, atherogenesis, and liver steatosis i

(PDF) Effect of Telmisartan, Angiotensin II Receptor Antagonist, on...

www.academia.edu

Effect of Telmisartan, Angiotensin II Receptor Antagonist, on Metabolic Profile in Fructose-Induced Hypertensive, Hyperinsulinemic, Hyperlipidemic Rats